As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Sponsored Content] Health Canada’s 14 September 2026 interim policy introduces flexibility in ethics reporting, investigator ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
The Hong Kong Department of Health has unveiled the timetable for launching its Centre for Medical Products Regulation (CMPR) and starting to approve medical products directly. In 2023, government ...
Patients who reviewed and signed a patient agreement form (PAF) for mifepristone and misoprostol under the US Food and Drug ...
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance laying out its proposed regulatory approach to ...
In a final guidance issued on Monday, the US Food and Drug Administration (FDA) laid out its expectations for cell and gene ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance on submitting investigational device exemption ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results